Article in ACS infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors.
Julie A TalbertDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37240, United States.
Sabrina K SpicerDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37240, United States.ORCID 0009-0008-3960-1221
Shannon D ManningDepartment of Microbiology, Genetics, and Immunology, Michigan State University, East Lansing, Michigan 48824, United States.
Jennifer A GaddyDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.ORCID 0000-0002-2192-4224
Steven D TownsendDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37240, United States.ORCID 0000-0001-5362-7235
Funding
Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Determining the contribution of zinc deficiency to perinatal Group B Streptococcus infectionsR01HD090061 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ARONOFF, DAVID M, GADDY, JENNIFER A · 2017 to 2021
$2.5M
The Role of macrophages in chorioamnionitis and group B streptococcal infectionsR01AI134036 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ARONOFF, DAVID M · 2017 to 2021
$2.4M
Acquisition of a Focused Ion Beam Scanning Electron Microscope with cryo-stageS10OD028704 · OD · VANDERBILT UNIVERSITY · PI TYSKA, MATTHEW J · 2022 to 2022
$1.6M
Utility of human milk oligosaccharides against the perinatal pathogen, Group B StreptococcusR01HD113675 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jennifer A Gaddy, Steven D. Townsend · 2024 to 2026
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Human Milk Oligosaccharides Mediate the Host-Microbe Interface in a Model Vaginal Community. · full record | OpenQuestion